Literature DB >> 6490241

Pharmacokinetics of the enantiomers of indoprofen in man.

V Tamassia, M G Jannuzzo, E Moro, S Stegnjaich, W Groppi, F B Nicolis.   

Abstract

Indoprofen, a non-steroidal analgesic and antiinflammatory drug whose activity and safety in man have been established in a large number of studies, has an asymmetric carbon atom and can therefore occur as either the (+) or the (-) enantiomer. As it has been shown that its pharmacological effects are almost entirely due to the (+) isomer (d-indoprofen), some pharmacokinetic properties of the latter have been studied in man in comparison with the racemic mixture given by oral administration, d-indoprofen is cleared from plasma and excreted in urine (as unchanged plus conjugated drug) at a slower rate than l-indoprofen. Moreover, no stereospecific inversion of d-indoprofen to the inactive enantiomer occurs after either single or repeated (one week) administration. The pharmacokinetic behaviour of d-indoprofen in the human organism appears to be the same after administration of the racemic form or of the dextro-enantiomer, when the latter is given at half the dose.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490241

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  8 in total

Review 1.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Authors:  F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

Review 3.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

Review 4.  Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.

Authors:  F Lapicque; N Muller; E Payan; N Dubois; P Netter
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

5.  Chiral bioequivalence: effect of absorption rate on racemic etodolac.

Authors:  J R Boni; J M Korth-Bradley; L S Richards; S T Chiang; D R Hicks; L Z Benet
Journal:  Clin Pharmacokinet       Date:  2000-12       Impact factor: 6.447

6.  The in vitro metabolic inversion of R(-) to S(+) indoprofen.

Authors:  V Rossetti; A Lombard; M Buffa; A Miglietta; A Oliviero; E Gadoni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jul-Sep       Impact factor: 2.441

7.  Stereoselective disposition of mexiletine in man.

Authors:  O Grech-Belanger; J Turgeon; M Gilbert
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

8.  Stereoselective disposition of indoprofen in surgical patients.

Authors:  S Björkman
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.